ERBB2 and breast cancer: Breast cancer is a highly heterogeneous disease encompassing distinct molecular subtypes—luminal A, luminal B, HER2-enriched, triple-negative, and basal-like—each defined by unique gene-expression profiles and showing different therapeutic responses and prognoses [17].